Scientist at EraCal Therapeutics - Schlieren, Zurich, Switzerland
Scientist
Contact Stephanie Niklaus
Chief Operating Officer
Contact Simon Breitler
CEO and Co-founder
Contact Josua Jordi
Member Scientific Advisory Board
Contact Gerd Oec
The preclinical biotech-company EraCal Therapeutics Ltd. is a spin-off of the University of Zurich and Harvard University, and develops first-in-class drugs to treat different diseases.